LRRK2 and Parkinson disease: Among the pathogenic LRRK2 mutations linked to PD, the substitution of Gly at amino acid 2019 to Ser (G2019S) is often considered the most common, and is not only found in familial PD, but is also observed in ∼1–5% of sporadic PD cases (Healy et al., 2008).